0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Glumetza:

Glumetza 500mg
Glumetza 750mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Glumetza:

  • Armenia
  • Australia
  • Austria
  • Barbados
  • Belarus
  • Belize
  • Bolivia
  • Brazil
  • Bulgaria
  • Costa Rica
  • Cuba
  • Ecuador
  • Estonia
  • Finland
  • Germany
  • Grenada
  • Guam
  • Guatemala
  • Hungary
  • India
  • Kuwait
  • Lebanon
  • Monaco
  • Morocco
  • Panama
  • Peru
  • Poland
  • Portugal
  • Romania
  • Saudi Arabia
  • Serbia
  • Seychelles
  • Singapore
  • Slovakia
  • South Africa
  • Tonga
  • Turkey
  • United Kingdom, UK
  • United States, US
  • Venezuela
View All Countries

Latest news releases on Glumetza:

Depomed To Present At Jefferies 2012 Global Health Care Conference - Yahoo Finance

Gralise™ (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN). Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized ...

Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf - Yahoo Finance

Gralise ® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN). Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized ...

Santarus to Present at Jefferies 2012 Global Healthcare Conference - Marketwatch

The company's current commercial efforts are focused on GLUMETZA(R) (metformin hydrochloride extended release tablets) and CYCLOSET(R) (bromocriptine mesylate) tablets, which are indicated as adjuncts to diet and exercise to improve glycemic ...

The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft - Press Releases - Boston Globe

Last month, Watson Pharma was in another patent infringement lawsuit, when the company announced the filing of an ANDA with the FDA for a generic version of Depomed Inc.’s (DEPO) diabetes drug, Glumetza. The drug is used as an adjunct to diet ...

Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc. - PR Newswire

Gralise™ (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN).  Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized by ...

Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting - Marketwatch

The company's current commercial efforts are focused on GLUMETZA(R) (metformin hydrochloride extended release tablets) and CYCLOSET(R) (bromocriptine mesylate) tablets, which are indicated as adjuncts to diet and exercise to improve glycemic ...

Santarus Reports First Quarter 2012 Financial Results - Seekingalpha.com

2 Other revenue included $10.3 million of GLUMETZA promotion revenue in the first quarter of 2011 Net income for the first quarter of 2012 was $0.6 million, diluted EPS was $0.01 and adjusted earnings before interest, tax, depreciation and amortization ...

Watson and Shire in Legal Battle - Analyst Blog - Boston Globe

Last month, Watson Pharma was in another patent infringement lawsuit, when the company announced the filing of an ANDA with the FDA for a generic version of Depomed Inc.’s (DEPO) diabetes drug, Glumetza. The drug is used as an adjunct to diet ...

Santarus, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report - new company profile report - Transworld News

The company also offers metformin hydrochloride extended release tablets under GLUMETZA brand, which acts as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Santarus distributes its products to a broad ...

4 Biotechs Looking At FDA Drug Approval Decisions In Q4 2012 - Seekingalpha.com

Ulcerative colitis is a form of inflammatory bowel disease. Santarus is a biotech company with four FDA approved drugs on the market: Glumetza and Cycloset for type 2 diabetes, Fenoglide for high cholesterol, and Zegerid an OTC drug for heartburn.

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK